155 related articles for article (PubMed ID: 11483646)
1. Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways.
D'Onofrio M; Cuomo L; Battaglia G; Ngomba RT; Storto M; Kingston AE; Orzi F; De Blasi A; Di Iorio P; Nicoletti F; Bruno V
J Neurochem; 2001 Aug; 78(3):435-45. PubMed ID: 11483646
[TBL] [Abstract][Full Text] [Related]
2. Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective.
Caraci F; Molinaro G; Battaglia G; Giuffrida ML; Riozzi B; Traficante A; Bruno V; Cannella M; Merlo S; Wang X; Heinz BA; Nisenbaum ES; Britton TC; Drago F; Sortino MA; Copani A; Nicoletti F
Mol Pharmacol; 2011 Mar; 79(3):618-26. PubMed ID: 21159998
[TBL] [Abstract][Full Text] [Related]
3. Native group-III metabotropic glutamate receptors are coupled to the mitogen-activated protein kinase/phosphatidylinositol-3-kinase pathways.
Iacovelli L; Bruno V; Salvatore L; Melchiorri D; Gradini R; Caricasole A; Barletta E; De Blasi A; Nicoletti F
J Neurochem; 2002 Jul; 82(2):216-23. PubMed ID: 12124422
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-beta neurotoxicity and clearance are both regulated by glial group II metabotropic glutamate receptors.
Durand D; Carniglia L; Turati J; Ramírez D; Saba J; Caruso C; Lasaga M
Neuropharmacology; 2017 Sep; 123():274-286. PubMed ID: 28495373
[TBL] [Abstract][Full Text] [Related]
5. Activation of mGlu3 receptors stimulates the production of GDNF in striatal neurons.
Battaglia G; Molinaro G; Riozzi B; Storto M; Busceti CL; Spinsanti P; Bucci D; Di Liberto V; Mudò G; Corti C; Corsi M; Nicoletti F; Belluardo N; Bruno V
PLoS One; 2009 Aug; 4(8):e6591. PubMed ID: 19672295
[TBL] [Abstract][Full Text] [Related]
6. Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis.
Battaglia G; Riozzi B; Bucci D; Di Menna L; Molinaro G; Pallottino S; Nicoletti F; Bruno V
Neurobiol Dis; 2015 Feb; 74():126-36. PubMed ID: 25434487
[TBL] [Abstract][Full Text] [Related]
7. Molecular signalling mediating the protective effect of A1 adenosine and mGlu3 metabotropic glutamate receptor activation against apoptosis by oxygen/glucose deprivation in cultured astrocytes.
Ciccarelli R; D'Alimonte I; Ballerini P; D'Auro M; Nargi E; Buccella S; Di Iorio P; Bruno V; Nicoletti F; Caciagli F
Mol Pharmacol; 2007 May; 71(5):1369-80. PubMed ID: 17293559
[TBL] [Abstract][Full Text] [Related]
8. The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling.
Bruno V; Sureda FX; Storto M; Casabona G; Caruso A; Knopfel T; Kuhn R; Nicoletti F
J Neurosci; 1997 Mar; 17(6):1891-7. PubMed ID: 9045718
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta.
Bruno V; Battaglia G; Casabona G; Copani A; Caciagli F; Nicoletti F
J Neurosci; 1998 Dec; 18(23):9594-600. PubMed ID: 9822720
[TBL] [Abstract][Full Text] [Related]
10. N-methyl-D-aspartate and TrkB receptors protect neurons against glutamate excitotoxicity through an extracellular signal-regulated kinase pathway.
Zhu D; Wu X; Strauss KI; Lipsky RH; Qureshi Z; Terhakopian A; Novelli A; Banaudha K; Marini AM
J Neurosci Res; 2005 Apr; 80(1):104-13. PubMed ID: 15744743
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotection of interleukin-6 against NMDA-induced neurotoxicity is mediated by JAK/STAT3, MAPK/ERK, and PI3K/AKT signaling pathways.
Fang XX; Jiang XL; Han XH; Peng YP; Qiu YH
Cell Mol Neurobiol; 2013 Mar; 33(2):241-51. PubMed ID: 23161148
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways.
Zhu Y; Culmsee C; Klumpp S; Krieglstein J
Neuroscience; 2004; 123(4):897-906. PubMed ID: 14751283
[TBL] [Abstract][Full Text] [Related]
13. The mammalian homologue of the novel peptide Bv8 is expressed in the central nervous system and supports neuronal survival by activating the MAP kinase/PI-3-kinase pathways.
Melchiorri D; Bruno V; Besong G; Ngomba RT; Cuomo L; De Blasi A; Copani A; Moschella C; Storto M; Nicoletti F; Lepperdinger G; Passarelli F
Eur J Neurosci; 2001 May; 13(9):1694-702. PubMed ID: 11359521
[TBL] [Abstract][Full Text] [Related]
14. The inhibition of glycogen synthase kinase 3beta by a metabotropic glutamate receptor 5 mediated pathway confers neuroprotection to Abeta peptides.
Liu F; Gong X; Zhang G; Marquis K; Reinhart P; Andree TH
J Neurochem; 2005 Dec; 95(5):1363-72. PubMed ID: 16277616
[TBL] [Abstract][Full Text] [Related]
15. Activation of p44/p42 MAP kinase in striatal neurons via kainate receptors and PI3 kinase.
Fuller G; Veitch K; Ho LK; Cruise L; Morris BJ
Brain Res Mol Brain Res; 2001 Apr; 89(1-2):126-32. PubMed ID: 11311983
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR.
Sanger H; Hanna L; Colvin EM; Grubisha O; Ursu D; Heinz BA; Findlay JD; Vivier RG; Sher E; Lodge D; Monn JA; Broad LM
Neuropharmacology; 2013 Mar; 66():264-73. PubMed ID: 22659090
[TBL] [Abstract][Full Text] [Related]
17. Synergism between fluoxetine and the mGlu2/3 receptor agonist, LY379268, in an in vitro model for antidepressant drug-induced neurogenesis.
Matrisciano F; Zusso M; Panaccione I; Turriziani B; Caruso A; Iacovelli L; Noviello L; Togna G; Melchiorri D; Debetto P; Tatarelli R; Battaglia G; Nicoletti F; Giusti P; Girardi P
Neuropharmacology; 2008 Feb; 54(2):428-37. PubMed ID: 18082849
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotection by metabotropic glutamate receptor glutamate receptor agonists: LY354740, LY379268 and LY389795.
Kingston AE; O'Neill MJ; Lam A; Bales KR; Monn JA; Schoepp DD
Eur J Pharmacol; 1999 Jul; 377(2-3):155-65. PubMed ID: 10456425
[TBL] [Abstract][Full Text] [Related]
19. Early defect of transforming growth factor β1 formation in Huntington's disease.
Battaglia G; Cannella M; Riozzi B; Orobello S; Maat-Schieman ML; Aronica E; Busceti CL; Ciarmiello A; Alberti S; Amico E; Sassone J; Sipione S; Bruno V; Frati L; Nicoletti F; Squitieri F
J Cell Mol Med; 2011 Mar; 15(3):555-71. PubMed ID: 20082658
[TBL] [Abstract][Full Text] [Related]
20. Glutamate activates GFAP gene promoter from cultured astrocytes through TGF-beta1 pathways.
Romão LF; Sousa Vde O; Neto VM; Gomes FC
J Neurochem; 2008 Jul; 106(2):746-56. PubMed ID: 18419760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
